“The efficacy and safety of intralesional sodium stibogluconate for the treatment of cutaneous Leishmaniasis in children under the age of two years ”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020027, Apr. 2020, doi: 10.4084/mjhid.2020.027.